{"title": "Tobias Dach auf LinkedIn: Ein Kalender f\u00fcrs Leben: Impfen f\u00fcr Jung und Alt - Pharma Fakten", "author": "Tobias Dach", "url": "https://www.linkedin.com/posts/tobias-dach_ein-kalender-f%C3%BCrs-leben-impfen-f%C3%BCr-jung-activity-7102741529818976256-Jzum", "hostname": "linkedin.com", "description": "Ein Kalender f\u00fcrs Leben: Impfen f\u00fcr Jung und Alt - Pharma Fakten", "sitename": "Linkedin", "date": "2023-08-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Tobias Dach](https://de.linkedin.com/in/tobias-dach?trk=public_post_feed-reaction-header) hat dies direkt geteilt\n[](https://de.linkedin.com/company/pharma-fakten?trk=public_post_reshare_feed-actor-image)\n1.376 Follower:innen\nEin\n[#innovatives](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Finnovatives&trk=public_post_reshare-text), [#gesundes](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fgesundes&trk=public_post_reshare-text), [#wohlhabendes](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fwohlhabendes&trk=public_post_reshare-text) [#Europa](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Feuropa&trk=public_post_reshare-text): [#Impfstoffunternehmen](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fimpfstoffunternehmen&trk=public_post_reshare-text) k\u00f6nnen dazu entscheidend beitragen. Die [#Politik](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpolitik&trk=public_post_reshare-text) ist gefragt: [https://lnkd.in/eTEHAQ8Z](https://lnkd.in/eTEHAQ8Z?trk=public_post_reshare-text) [](https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fpharma-fakten%2Ede%2Fnews%2Fein-kalender-fuers-leben-impfen-fuer-jung-und-alt%2F&urlhash=xS2A&trk=public_post_reshare_feed-article-content)\nLinkedIn und Drittanbieter setzen essenzielle und nicht zwingend erforderliche Cookies ein, um die LinkedIn Dienste bereitzustellen, zu sch\u00fctzen, zu analysieren und zu verbessern und um auf LinkedIn und au\u00dferhalb von LinkedIn relevante Anzeigen zu pr\u00e4sentieren (einschlie\u00dflich zielgruppenspezifischer Anzeigen und Stellenanzeigen). Weitere Informationen finden Sie in unserer\n[Cookie-Richtlinie](https://www.linkedin.com/legal/cookie-policy).\nW\u00e4hlen Sie \u201eAkzeptieren\u201c, um dieser Nutzung zuzustimmen, oder w\u00e4hlen Sie \u201eAblehnen\u201c, um die nicht zwingend erforderlichen Cookies abzulehnen. Sie k\u00f6nnen Ihre Auswahl jederzeit in den\n[Einstellungen](https://www.linkedin.com/mypreferences/g/guest-cookies) aktualisieren. [Tobias Dach](https://de.linkedin.com/in/tobias-dach?trk=public_post_feed-reaction-header) hat dies direkt geteilt\n1.376 Follower:innen\nEin\n[#innovatives](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Finnovatives&trk=public_post_reshare-text), [#gesundes](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fgesundes&trk=public_post_reshare-text), [#wohlhabendes](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fwohlhabendes&trk=public_post_reshare-text) [#Europa](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Feuropa&trk=public_post_reshare-text): [#Impfstoffunternehmen](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fimpfstoffunternehmen&trk=public_post_reshare-text) k\u00f6nnen dazu entscheidend beitragen. Die [#Politik](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpolitik&trk=public_post_reshare-text) ist gefragt: [https://lnkd.in/eTEHAQ8Z](https://lnkd.in/eTEHAQ8Z?trk=public_post_reshare-text)\nZum Anzeigen oder add a comment\n[einloggen](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_feed-cta-banner-cta)\n289 Follower:innen", "language": null, "image": "https://media.licdn.com/dms/image/sync/D4E27AQFm741sNIItKQ/articleshare-shrink_800/0/1697885496245?e=1699084800&v=beta&t=ZhqrKzHEh1mcoxgksH-3g9Vc2yHLZOBDxgUyPmJ1vyM", "pagetype": "article", "links": ["https://www.linkedin.com/legal/cookie-policy", "https://www.linkedin.com/mypreferences/g/guest-cookies", "/legal/user-agreement?trk=public_post_google-auth-button_user-agreement", "/legal/privacy-policy?trk=public_post_google-auth-button_privacy-policy", "/legal/cookie-policy?trk=public_post_google-auth-button_cookie-policy", "#main-content", "/?trk=public_post_nav-header-logo", "https://www.linkedin.com/pulse/topics/home/?trk=public_post_guest_nav_menu_articles", "https://www.linkedin.com/pub/dir/+/+?trk=public_post_guest_nav_menu_people", "https://www.linkedin.com/learning/search?trk=public_post_guest_nav_menu_learning", "https://www.linkedin.com/jobs/search?trk=public_post_guest_nav_menu_jobs", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_nav-header-join", "https://www.linkedin.com/login?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&fromSignIn=true&trk=public_post_nav-header-signin", "https://de.linkedin.com/in/tobias-dach?trk=public_post_feed-reaction-header", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://de.linkedin.com/company/pharma-fakten?trk=public_post_reshare_feed-actor-image", "https://de.linkedin.com/company/pharma-fakten?trk=public_post_reshare_feed-actor-name", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Finnovatives&trk=public_post_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fgesundes&trk=public_post_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fwohlhabendes&trk=public_post_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Feuropa&trk=public_post_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fimpfstoffunternehmen&trk=public_post_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpolitik&trk=public_post_reshare-text", "https://lnkd.in/eTEHAQ8Z?trk=public_post_reshare-text", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fpharma-fakten%2Ede%2Fnews%2Fein-kalender-fuers-leben-impfen-fuer-jung-und-alt%2F&urlhash=xS2A&trk=public_post_reshare_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Ftobias-dach_ein-kalender-f%25C3%25BCrs-leben-impfen-f%25C3%25BCr-jung-activity-7102741529818976256-Jzum&trk=public_post_feed-cta-banner-cta", "https://de.linkedin.com/posts/tobias-dach_k%C3%BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_k%25C3%25BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fwirkstoffsuche&trk=public_post_main-feed-card-text", "https://lnkd.in/dmpU66Ja?trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpfecolleague&trk=public_post_main-feed-card-text", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fconversationleaders%2Epfizer%2Ecom%2Fmember%2Fpost%2F1bab73d7-30ac-431c-84a6-9eafbca9a959%3Fuc%3D72605%26g%3Dc98d9880-701e-4eb7-bb1a-31b4e67026db%26f%3D291016&urlhash=2nHL&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_k%25C3%25BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_k%25C3%25BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_k%25C3%25BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_k%25C3%25BCnstliche-intelligenz-in-der-arzneimittelforschung-activity-7122832482919432192-YIcP&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/tobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fki&trk=public_post_main-feed-card-text", "https://lnkd.in/d-X__a23?trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpfecolleague&trk=public_post_main-feed-card-text", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fconversationleaders%2Epfizer%2Ecom%2Fmember%2Fpost%2Fd8c8dca3-bb1f-4b16-8e7e-4bbf0c15d1cb%3Fuc%3D72605%26g%3Df2bb44c3-5a5d-4c33-a9a2-d54d9da67db9%26f%3D291014&urlhash=0_IB&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_podcast-charles2-start-einer-episoden-reihe-activity-7122832420319457280--CAf&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/tobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fkrebs&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Ftabuthema&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fenttabuisieren&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fstuhlkreisen&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fapp&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fdigitalisierung&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Finterview&trk=public_post_main-feed-card-text", "https://lnkd.in/eWz6t_Ef?trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpfecolleague&trk=public_post_main-feed-card-text", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fconversationleaders%2Epfizer%2Ecom%2Fmember%2Fpost%2F4cd8c994-9fab-4f0e-9016-dba4779938d3%3Fuc%3D72605%26g%3De563e7ec-fc1c-4a4e-a93e-20286ce8641e%26f%3D290722&urlhash=dmpc&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_interview-mit-simone-adelsbach-von-yeswecan-activity-7121052955163639808-S1HG&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/tobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fvielfalt&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpfecolleague&trk=public_post_main-feed-card-text", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fconversationleaders%2Epfizer%2Ecom%2Fmember%2Fpost%2F1520e593-dda7-4725-82d3-893cbc5f20dc%3Fuc%3D72605%26g%3Ddc525303-f82e-4910-9f8d-29f20b0850a5%26f%3D289984&urlhash=-sc4&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_vielfalt-in-der-klinischen-forschung-activity-7117392941878267904-szm5&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/tobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/in/tobias-dach?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fdiversity&trk=public_post_main-feed-card-text", "https://lnkd.in/ehH8DKzZ?trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2Fpfecolleague&trk=public_post_main-feed-card-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Ftobias-dach_pfizer-diversity-talk-am-16-oktober-2023-activity-7116394772776263680-1grs&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fin%2Ftobias-dach%2Frecent-activity%2F&trk=public_post_follow-posts", "https://de.linkedin.com/in/tobias-dach?trk=public_post_follow-view-profile", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Ffeed%2Fupdate%2Furn%3Ali%3Aactivity%3A7102741529818976256&trk=public_post_follow", "https://about.linkedin.com?trk=d_public_post_footer-about", "https://www.linkedin.com/accessibility?trk=d_public_post_footer-accessibility", "https://www.linkedin.com/legal/user-agreement?trk=d_public_post_footer-user-agreement", "https://www.linkedin.com/legal/privacy-policy?trk=d_public_post_footer-privacy-policy", "https://www.linkedin.com/legal/cookie-policy?trk=d_public_post_footer-cookie-policy", "https://www.linkedin.com/legal/copyright-policy?trk=d_public_post_footer-copyright-policy", "https://brand.linkedin.com/policies?trk=d_public_post_footer-brand-policy", "https://www.linkedin.com/psettings/guest-controls?trk=d_public_post_footer-guest-controls", "https://www.linkedin.com/legal/professional-community-policies?trk=d_public_post_footer-community-guide", null]}